DIMINO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 188
EU - Europa 90
AS - Asia 7
Totale 285
Nazione #
US - Stati Uniti d'America 188
IT - Italia 47
DE - Germania 13
GB - Regno Unito 13
FI - Finlandia 7
IE - Irlanda 4
CN - Cina 3
ES - Italia 2
IN - India 2
SE - Svezia 2
DK - Danimarca 1
FR - Francia 1
HK - Hong Kong 1
TR - Turchia 1
Totale 285
Città #
Chandler 49
Ashburn 40
New York 18
Palermo 13
Medford 9
Fairfield 8
Helsinki 6
Lawrence 6
Princeton 6
Altamura 5
Ludwigshafen am Rhein 5
Rome 5
San Diego 5
Houston 4
Padova 4
Bremen 3
Dublin 3
Wilmington 3
Beijing 2
Foggia 2
London 2
Munich 2
Pune 2
Seattle 2
Woodbridge 2
Zaragoza 2
Acton 1
Athlone 1
Bologna 1
Central 1
Chiswick 1
Conegliano 1
Copenhagen 1
Edinburgh 1
Fulham 1
Guangzhou 1
Hounslow 1
Izmir 1
Kilburn 1
La Châtre 1
Lappeenranta 1
Mehlingen 1
Messina 1
Milan 1
Milazzo 1
New Bedfont 1
Nottingham 1
Partinico 1
San Jose 1
San Paolo di Civitate 1
Southwark 1
Verona 1
Washington 1
Totale 235
Nome #
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes 53
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome 47
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement 47
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 43
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 42
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength 32
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 22
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab 20
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 18
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 14
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 6
Totale 344
Categoria #
all - tutte 3.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.390


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202269 0 0 0 0 17 0 0 6 2 13 21 10
2022/2023130 6 24 3 17 12 15 0 19 8 4 17 5
2023/2024145 8 16 13 23 8 37 12 14 0 14 0 0
Totale 344